Saint Kitts and Nevis
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Saint Kitts and Nevis (KN)
2000 | 3.1 thousand |
2011 | 2.9 thousand |
2024 | 5.0 thousand |
2050 | 6.1 thousand |
Saint Kitts and Nevis is one of the 22 countries and territories in the IDF North America and Caribbean Region. Saint Kitts and Nevis has the fourth highest diabetes prevalence (20-79 years) in the Region.
Data source(s) used for the diabetes estimates in adults:
- WHO STEPS 2008
2000
2011
2024
2050
Loading...
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 3.1 | 2.9 | 5.0 | 6.1 |
Age-standardised prevalence of diabetes, % | 12.1 | 8.5 | 13.8 | 15.8 |
Proportion of people with undiagnosed diabetes, % | - | - | 24.5 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 1.2 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 1.5 | 1.6 |
Age-standardised prevalence of IFG, % | - | - | 4.1 | 4.3 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 3.7 | 2.0 | 2.4 |
Age-standardised prevalence of IGT, % | - | 11.0 | 5.6 | 6.2 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 40.0 | 71.7 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 21.7 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 5.6 | 5.7 |
Total diabetes-related health expenditure, ID million | - | - | 8.7 | 9.0 |
Diabetes-related health expenditure per person, USD | - | 881.0 | 1,103.4 | 939.3 |
Diabetes-related health expenditure per person, ID | - | - | 1,729.2 | 1,472.1 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | - | - |
People with type 1 diabetes (0-19 y) | - | - | - | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 26.0 | 33.4 | 34.7 | 35.2 |
Population of children and adolescents (0-19 y) | - | - | - | - |
Loading...
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 3.1 |
Age-standardised prevalence of diabetes, % | 12.1 |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 26.0 |
Population of children and adolescents (0-19 y) | - |